EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The role of Fetuin-A and Leucine-rich α-2-glycoprotein in the diagnosis of prostate cancer - a pilot study

Alena Sorokac Kubolkova, Gabriel Varga, Miroslava Benovska, Lenka Kovacova, Michal Fedorko

Biomedical Papers · 2025

DOI: 10.5507/bp.2024.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Papers, 2025. Verfasst von Alena Sorokac Kubolkova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Hospital Brno, Brno, Czech Republic. Hauptthemen laut MEDLINE: Prostatic Neoplasms, alpha-2-HS-Glycoprotein, Biomarkers, Tumor, Glycoproteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Prostate cancer (PC) is one of the most frequently diagnosed non-skin solid cancers and is a leading cause of cancer-related death and the incidence increasing. Early diagnosis of the disease improves the outcomes. There is an urgent need for new biomarkers with greater discriminative precision for diagnosis, risk-stratification and treatment. The aim of our study was to evaluate the diagnostic and prognostic potential of Fetuin-A and LRG1 in patients with PC. METHODS: Serum levels of Fetuin-A and LRG1 were compared in patients with PC (n=46), a control group 1 including young, healthy subjects (n=26) and control group 2 including patients with negative prostate biopsy (n=46). In PC patients, the levels of both biomarkers were compared in subgroups with different tumour characteristics. RESULTS: We demonstrated a statistically significant higher concentrations of Fetuin-A in PC patients compared to control group 2 (439 mg/L vs. 372 mg/L), P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic Neoplasmsalpha-2-HS-GlycoproteinBiomarkers, TumorGlycoproteinsHumansMalePilot ProjectsMiddle AgedAgedCase-Control StudiesPrognosisAdult

Stichwörter der Autor:innen

Fetuin-ALRG1biomarkerprostate cancerserum

Substanzen

alpha-2-HS-GlycoproteinBiomarkers, TumorLRG1 protein, humanGlycoproteins

Autor:innen und Institutionen

  • Department of Urology, University Hospital Brno, Brno, Czech Republic.
  • Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Department of Laboratory Methods, University Hospital Brno, Brno, Czech Republic.
  • Institute of Health Information and Statistics of the Czech Republic, Brno, Czech Republic.

Zitieren

APA

Sorokac Kubolkova, A., Varga, G., Benovska, M., Kovacova, L., & Fedorko, M. (2025). The role of Fetuin-A and Leucine-rich α-2-glycoprotein in the diagnosis of prostate cancer - a pilot study. Biomedical Papers. https://doi.org/10.5507/bp.2024.028

Vancouver

Sorokac Kubolkova A, Varga G, Benovska M, Kovacova L, Fedorko M. The role of Fetuin-A and Leucine-rich α-2-glycoprotein in the diagnosis of prostate cancer - a pilot study. Biomedical Papers. 2025. doi:10.5507/bp.2024.028

BibTeX
@article{SorokacKubolkova2025,
  author = {Sorokac Kubolkova, Alena and Varga, Gabriel and Benovska, Miroslava and Kovacova, Lenka and Fedorko, Michal},
  title = {The role of Fetuin-A and Leucine-rich α-2-glycoprotein in the diagnosis of prostate cancer - a pilot study},
  journal = {Biomedical Papers},
  year = {2025},
  doi = {10.5507/bp.2024.028}
}
Kostenlos starten →